Hyperliquid Strategies (NASDAQ:PURR - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Saturday.
Several other equities analysts also recently commented on PURR. Chardan Capital increased their price target on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a "buy" rating in a report on Friday. Cantor Fitzgerald set a $22.60 price objective on Hyperliquid Strategies and gave the company an "overweight" rating in a research report on Thursday. Finally, Weiss Ratings raised Hyperliquid Strategies from a "sell (d)" rating to a "sell (d+)" rating in a report on Wednesday, June 3rd. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $16.53.
Get Our Latest Stock Report on Hyperliquid Strategies
Hyperliquid Strategies Stock Down 9.5%
Shares of NASDAQ:PURR traded down $1.22 on Friday, reaching $11.61. The company had a trading volume of 37,819,591 shares, compared to its average volume of 17,643,562. The stock has a market capitalization of $1.68 billion, a P/E ratio of -1.58 and a beta of 1.71. The stock has a 50-day moving average price of $7.86 and a 200 day moving average price of $6.88. Hyperliquid Strategies has a twelve month low of $3.01 and a twelve month high of $14.14.
Institutional Investors Weigh In On Hyperliquid Strategies
Hedge funds and other institutional investors have recently made changes to their positions in the company. EHP Funds Inc. acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at $302,000. HRT Financial LP acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $856,000. Jane Street Group LLC acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $339,000. GM Advisory Group LLC acquired a new stake in Hyperliquid Strategies in the fourth quarter worth about $2,946,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Hyperliquid Strategies during the 4th quarter worth about $156,000. 9.45% of the stock is owned by institutional investors and hedge funds.
Hyperliquid Strategies News Summary
Here are the key news stories impacting Hyperliquid Strategies this week:
- Positive Sentiment: Hyperliquid Strategies reported fiscal 2026 net income of approximately $305.5 million and highlighted major operational progress, including more than doubling its HYPE treasury, launching a large network validator and completing its exit from legacy biotech operations. Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
- Positive Sentiment: The company disclosed a HYPE position valued at roughly $1.9 billion, with its treasury reportedly reaching about 29.3 million tokens. Investors appear to be treating the treasury as a direct way to gain exposure to the Hyperliquid ecosystem. Hyperliquid Strategies Shares Rise After Reporting $1.9B HYPE Position
- Positive Sentiment: HYPE reached a record price near $84.80, increasing the reported value of Hyperliquid Strategies’ token holdings and supporting the stock’s momentum. Hyperliquid HYPE Surges to Record $84.80
- Neutral Sentiment: Chardan Capital reaffirmed a Buy rating and raised its outlook, but its reported $9.75 price target is below the stock’s recent trading level, suggesting analysts may be lagging the rally or see limited near-term upside. Why Is Hyperliquid Strategies Stock Up on Friday?
- Negative Sentiment: Technical commentary warns that the HYPE rally may be becoming stretched, while the company’s results and valuation remain highly sensitive to cryptocurrency prices. A reversal in HYPE could reduce the value of PURR’s treasury and pressure the shares. Hyperliquid Price Forecast
Hyperliquid Strategies Company Profile
(
Get Free Report)
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Hyperliquid Strategies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperliquid Strategies wasn't on the list.
While Hyperliquid Strategies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.